tepadina 100 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina 15 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina 15 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina 15 mg
mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
thiotepa riemser 100 mg
a.l. medi-market ltd. - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg/vial - thiotepa - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
thiotepa riemser 15 mg
a.l. medi-market ltd. - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg/vial - thiotepa - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
tepadina powder for solution
adienne sa - thiotepa - powder for solution - 400mg - thiotepa 400mg
thiotepa for injection usp powder for solution
sterimax inc - thiotepa - powder for solution - 15mg - thiotepa 15mg
thiotepa for injection usp powder for solution
sterimax inc - thiotepa - powder for solution - 100mg - thiotepa 100mg
tepadina powder for concentrate for solution for infusion 100mgvial
axxessbio pte. ltd. - thiotepa - injection, powder, lyophilized, for solution - thiotepa 100mg/vial